Sidonio discussed how fitusiran may improve the treatment landscape and reduce treatment burden for people with hemophilia A or B with or without inhibitors.
Robert F. Sidonio, Jr., MD, MSc
Advertisement
Articles by Robert F. Sidonio, Jr., MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Enlicitide for LDL-C Lowering in Adults With Hypercholesterolemia
2
What New 26-Week COMP006 Data Mean for TRD, With Boadie Dunlop, MD
3
Daily Inhaled TPIP Improved PAH Measures at 12 Months in OLE
4
FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD
5